Sign In

Meena Arora

Global Medical Affairs & Drug Development Leader

Meena Arora studied at the University of Surrey before establishing herself as a medical expert in the pharmaceutical industry. She is currently the Head of Medical Affairs at Amryt Pharma plc, a prominent pharmaceutical company that offers treatments for rare and orphan diseases. Arora's professional experience includes extensive knowledge in the medical field, particularly in medical affairs, pharmacology, and clinical trials. She has a reputable skill set that involves an ability to coordinate with medical and clinical teams, design innovative strategies related to clinical trials, and manage product portfolios. Arora has also contributed significantly to academic research and is a prolific writer of medical papers.

Highlights

Jun 8 · linkedin

EB understanding, EB education and EB awareness. #epidermolysisbullosa #eb #raredisease #patientoutcomes

Apr 17 · linkedin

As an author, I am delighted to announce that the paper entitled “Mapping the burden of severe forms of epidermolysis bullosa – implications for patient management” has been published in JAAD international. The journal pre-proof is available, you can find it at https://lnkd.in/ejwNuS7i

In this paper, Amryt in collaboration with global epidermolysis bullosa (EB) Experts; Professor Jemma Mellerio (UK), Dr Anna Martinez (UK), Professor Peter Marinkovich (US), Professor Dimitra Kiritsi (Germany), Kellie Badger (US) and Nati Ramero Haro (Spain) reviewed the current literature on the challenges faced by EB patients, whereby published literature and clinical experience was then used to construct a conceptual framework to visually communicate the relationship between disease pathophysiology and patient-relevant outcomes.

This paper will be of significant interest to clinicians and researchers working in the field of dermatology, as well as to patient advocacy groups and policymakers. By providing a comprehensive overview of the burden of EB and its impact, we hope to raise awareness of the disease and inspire approaches to treatment and care. #collaboration #epidermolysisbullosa #burdenmapping #eb #patientcentricity

Related Questions

What are Meena Arora's key achievements at Onconova Therapeutics?
How did Meena Arora transition from pharmaceuticals to academic operations?
What is Meena Arora's educational background?
What projects has Meena Arora led at Traws Pharma, Inc?
How long has Meena Arora been in her current role at Onconova Therapeutics?
Meena Arora
Meena Arora, photo 1
Meena Arora, photo 2
Add to my network

Location

United Kingdom